Following the postponement of the BioProcess International (BPI) US West Conference, Santa Clara in March 2020, Duncan Borthwick speaks to Mark Stockdale about the talk he was due to give, “Total Cell Line Development – A Holistic A-Z Approach for Scientists Planning A CLD Lab” Mark discusses the changes in Cell Line Development (CLD) workflows, …
Bournemouth, UK, 2nd March 2020 / Sciad Newswire / Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEO. Mark joined Solentim in October 2019 as Chief Marketing Officer. As CEO, Mark will work with the Company founders and executive team to deliver and execute a …
Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be exhibiting at the 3rd annual Bioprocessing Summit Europe, taking place 24-26 March 2020 in Barcelona. European life science is thriving, with world-class research institutions and medical centres, and 16 of the world’s top 50 universities for life sciences[1]. Bioprocessing …
Life science in the Nordic region is thriving. Sweden ranked as the European Union ‘innovation leader’ for 2019 in the European Innovation Scoreboard and the area has overtaken other prominent areas including the UK, Germany and Switzerland. We are pleased to be joining other innovators and experts at the 3rd annual Biologics World Nordic conference, …
Read more Join Solentim in meeting Europe’s leading innovators at Biologics World Nordic
Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be exhibiting at ELRIG’s second CRISPR in Drug Discoveryconference, 4-5 March 2020 at the Babraham Institute in Cambridge. Focusing on the applications of genome engineering throughout the drug discovery pipeline, attendees will gain unique insights into the industry ‘From Targets …
Read more Insights and advances in CRISPR, cell line development and drug discovery
Enrichment by FACS combined with Solentim’s VIPS & Cell Metric cut CLD workflow timelines at a major European CDMO by nearly 50% and reduced plate numbers by up to 96% Celonic AG, a premium biologics contract development and manufacturing organisation (CDMO) specialising in mammalian cell line production, came to Solentim looking for new technologies to …
